Atlas Trials

A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients

Clinical trial NCT06583993 · RECRUITING

Trial details

NCT number
NCT06583993
Sponsor
Shanghai Changzheng Hospital
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Intrahepatic Cholangiocarcinoma
Start date
2024-11-07
Primary completion
2026-05-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.